15.09.2023 • News

Sanner Group Opens Second Manufacturing Facility in China

Sanner, a German contract manufacturing and development organization (CDMO), is expanding its production capacity in the Asia-Pacific region with the opening of a second manufacturing facility in Kunshan, China.

According to Sanner, the new 18,000 m2 facility Kunshan II will boost production capacity by 80% which enables the company to meet demand across the region for Sanner’s pharmaceutical and medical technology products.

Ralf Tiemann, Sanner CEO Asia-Pacific, said: “The new facility marks an important milestone in the successful 23-year history of Sanner China and will substantially enhance our offering to customers in this vital region. With Kunshan II onstream we’ll be able to reliably meet growing demand, providing all our customers with products of outstanding quality backed by exceptional service.”

The construction and commissioning of Kunshan II is just one element of the company’s growth plans, said Sanner, which will include developments in Asia Pacific in addition to expansion in Germany. A new production facility and headquarters planned for the company’s Bensheim site is scheduled to come onstream in September 2024, to more than double current production capacity in Germany.

Source: Sanner
Source: Sanner

Company

Logo:

Sanner GmbH

Bertha-Benz-Straße 5
64625 Bensheim
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read